USPTO serial 88050032
LACROMIN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 14, 2019
- Examiner
- YOUNG, THOMAS PAUL
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with LACROMIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Junction City, KS
Junction City, KS
Junction City, KS
JUNCTION CITY, KS
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Crissa A. Cook
Crissa A. Cook HOVEY WILLIAMS LLP10801 MASTIN BLVD., SUITE 1000OVERLAND PARK, KS 66210-1697United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Recombinant human lactoferrin derived from a nonmammalian host for use in cell culture media for scientific and research use and for use as a diagnostic preparations for scientific and research use | ACTIVE | Nov 18, 2005 |
| 005 | Recombinant human lactoferrin derived from a nonmammalian host for use in cell culture media for bioprocessing, namely, cell culture media for cultivation of human, animal, plant, and microorganism cells for commercial use | ACTIVE | Nov 18, 2005 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ventria Bioscience Inc.
- Other trademarks owned by Ventria Bioscience Inc.
- Other trademarks owned by Ventria Bioscience Inc.
- Other trademarks owned by INVITRIA, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named LACROMIN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Feb 12, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Feb 12, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 12, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 3, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 14, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 13, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 14, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 26, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 26, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 6, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 19, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jan 4, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 3, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 2, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 2, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 2, 2018 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Nov 2, 2018 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Nov 2, 2018 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Nov 2, 2018 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Nov 1, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 27, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 27, 2018 | NWAP | NEW APPLICATION ENTERED | — |